Liver cancer treatment tends to be comprehensive treatment

Treatment has made the slowest progress in liver cancer research, and there is still no drug that is specifically effective for liver cancer. Early surgery has also failed to solve the problem of subsequent recurrence and metastasis.

Recently, there has been a general trend toward comprehensive treatment.

Early comprehensive treatment is beneficial to improving the long-term survival rate.

Comprehensive treatment in the middle stage will improve the survival of more than half of liver cancer patients. Currently, the five-year survival rate of liver cancer patients is only about 2%, and the median survival period is only 2 to 3 months. If comprehensive treatment for patients in the middle stage can be promoted, it is possible to improve the survival of all liver cancer patients.

Comprehensive treatment in the late stage will reduce the pain and improve the symptoms of about half of liver cancer patients, allowing them to pass through the final stage, which is short but relatively stable.

Therefore, the exploration of comprehensive treatment will undoubtedly be the focus of liver cancer treatment research for a long time. In comprehensive treatment, the study of traditional Chinese medicine is an important link. This is an advantage of Chinese medicine, and how to give full play to its characteristics still requires in-depth exploration.